bioRN Lounge September 2026: InTraSeq technology: a multimodal single cell method for simultaneous measurement of RNA and Proteins to uncover new single cell biology

bioRN Lounge September 2026: InTraSeq technology: a multimodal single cell method for simultaneous measurement of RNA and Proteins to uncover new single cell biology

At our monthly networking event, we welcome representatives from biotech and life science companies in the bioRN Life Science Cluster, as well as scientists from our research institutes. After a short update of bioRN cluster activities and news, an invited speaker from the network presents and discusses scientific trends, breakthrough techniques, outstanding research, and more with the participants.
Join us for an exciting talk on the topic:

InTraSeq technology: a multimodal single cell method for simultaneous measurement of RNA and Proteins to uncover new single cell biology

  • Multimodal Measurement: InTraSeq bridges the gap in standard single cell transcriptomics by simultaneously measuring RNA and intracellular proteins, along with post-translational modifications (PTMs) from the same cell, allowing for a more complete picture of cellular functional states.
  • Workflow Efficiency & Compatibility: The technology is highly compatible with existing workflows, integrating seamlessly with the 10x Genomics 3′ single-cell and Flex/Apex assays.
  • Measure Signaling Pathway Activation Directly from Your Data: Gain insights into signaling pathway activity without relying only on inferred activity from transcriptomic data.
  • Enhanced Biological Insight: By capturing RNA-protein correlations and signaling pathway dynamics that RNA sequencing alone misses, InTraSeq enables the identification of new cell subtypes and provides higher-resolution mapping of differentiation trajectories and complex signaling.

Speaker: Henk P.J. Buermans, PhD,  Senior Field Application Scientist at Cell Signaling

The bioRN Lounge is officially sponsored by GSK.

register now

Our latest News

discover more
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

Ridgefield, CT, USA, July 9, 2026 – BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim today announced the launch of a new research team at XSeed Labs, the established innovation incubator embedded within Boehringer’s U.S. R&D headquarters in Ridgefield, Connecticut. The newly established research team, Team NIB (New Platform for Next-Generation Intraocular […]

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Researchers at Heidelberg University’s Faculty of Medicine are investigating a new care model for older adults with mild strokes at the Heidelberg University Hospital’s Department of Neurology. The Joint Federal Committee (G-BA) is funding the ARTIFICE study with approximately 2.4 million euros. Full Text in German below. Klinische Studie zu leichtem Schlaganfall: stationär oder ambulant […]

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

Ardigen platform supports VERAXA’s in-house AI capabilities to optimize cancer target pair selection for conditionally active t cell engagers (TCEs) and antibody drug conjugates (ADCs) ZURICH, SWITZERLAND – July 13, 2026 — VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced a collaboration with Ardigen S.A., an AI-driven computational partner for modern […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp